Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease
M. Marietti(5T Torino (Italy)), E. Bugianesi(University of Turin), Antonina Smedile(Ospedale Papa Giovanni XXIII), Chiara Saponaro(University of Pisa), C. Rosso(University of Turin), Holger Jon Møller(Aarhus University), Amalia Gastaldelli(National Research Council), K. Kazankov(Aarhus University Hospital), Hendrik Vilstrup(Aarhus University Hospital), Henning Grønbæk(Aarhus University Hospital), Giorgio Maria Saracco(Ospedale Maggiore), E. Buzzigoli(Istituto di Fisiologia Clinica), Jacob George(The University of Sydney), Gian Paolo Caviglia(Department of Medical Sciences), M.L. Abate(University of Turin), Melania Gaggini(Istituto di Fisiologia Clinica)
Cited by 1
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
|Nutrients|2013|821
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
|Nutrients|2015|530
Serum levels of IGF‐I, IGFBP‐3 and colorectal cancer risk: results from the EPIC cohort, plus a meta‐analysis of prospective studies
|International Journal of Cancer|2009|241
The Kruppel-Like Factor 6 Genotype Is Associated With Fibrosis in Nonalcoholic Fatty Liver Disease
|Gastroenterology|2008|196